Cadence Neuroscience Appoints Medtech Executive Chris Cronin as CEO to Lead Clinical Execution and Platform Growth

Positive

AI Analysis

Summary

Cadence Neuroscience appointed Chris Cronin, a veteran medtech executive, as CEO to lead clinical execution and platform growth, with founder Kent Leyde transitioning to CTO for technology and product development.

Importance:2/10

Sentiment:

0.30

management changeCEO appointmentneuromodulationleadership

Read the original article

Published by PR Newswire Clinical Trials on September 22, 2026 1:00 PM

Read Original